Authors
Latest:
Cyclosporine drop for treating dry eye offers new advantagesDelivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation
Latest:
One shingle at a time: Starting a solo practiceSometimes, the best job for you is the one you create.
Latest:
IVIg, ICVM may help patients with small fiber neuropathy, neuropathic corneal painNCP should be considered for patients with discomfort, irritation, dryness, grittiness.
Latest:
Take-Home Points for the Treatment of AMD and DMEDavid A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
Adherence and tolerability are key in treatment of hypertension and glaucomaPriorities can ensure optimal outcomes for patients diagnosed with diseases.
Latest:
Tools can detect corneal nerve damage earlyNoncontact esthesiometry screens for all levels of neurotrophic keratitis.
Latest:
Investigators research ocular health after space flightSpaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Latest:
Next-generation MGD: Patients in their 20s, 30s offer new perspectivesLong-term screen users and contact lens wearers in group face challenges.
Latest:
Blog: MRI findings of undereye filler and filler migrationHyaluronic acid fillers are used for undereye volume correction, detailing aging effects on facial anatomy, common complications, and optimal injection techniques. Imaging tools such as MRI can prove to be beneficial for patient assessment.
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
Two-year results of laser scleral microporationProcedure can reduce scleral biomechanical stiffness and rejuvenate dynamic range of focus.
Latest:
From waste to wonder: Transformational advances in scleral allograft technologyUnlocking the potential of donor scleral tissue: Innovations and future applications.
Latest:
A portable solution for high-definition slit lamp imagingTAKE-HOME: This affordable device allows the view through a slit lamp to be shared in real time or recorded, for teaching and reference purposes.
Latest:
Investigators research ocular health after space flightSpaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Latest:
Future of Intravitreal InjectionNadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.
Latest:
Safety of Advanced Therapies in Clinical Trials vs Real World ExperienceLisa J. Faia, MD asks the panel about their concerns regarding the safety of newer agents for the broad array of retinal vascular diseases, highlighting the similarities and differences between clinical trial outcomes and real-world results.
Latest:
Office-based vitrectomy a viable alternative to hospital, surgeryThe option is a definitive step forward in the field of vitreoretinal surgery
Latest:
EyeCon 2024: Program co-chair Oluwatosin U. Smith, MD, talks about her love for research and educationFrom surgeon to mentor: Smith fuels her commitment to improving glaucoma care by training future ophthalmologists.
Latest:
Standardizing terminology for clarity in refractive surgeryLanguage can drive understanding, trust, and better outcomes for patients
Latest:
Clearing hurdles to large scale telemedicine adoptionDuring the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Latest:
Partners collaborate on integration of AI-supported ROP telemedicine globallySiloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.
Latest:
Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.
Latest:
The benefits of cryopreserved amniotic membrane during COVID-19CAM’s regenerative healing means long-term relief and fewer visits to clinic.
Latest:
Listening to the heart: Lessons from cardiology in remote monitoring and AIPhysicians explore how other specialties adopted and integrated remote monitoring into plans.
Latest:
The untapped potential of cell and gene therapy as treatment optionInvestigators continue to break new ground, giving hope to patients, physicians.
